Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1990 2
1991 1
1993 1
1994 1
1995 1
1996 2
1997 2
1998 1
1999 7
2000 2
2001 3
2002 4
2003 1
2004 2
2005 3
2006 6
2007 4
2008 8
2009 5
2010 11
2011 11
2012 9
2013 11
2014 11
2015 11
2016 10
2017 9
2018 10
2019 22
2020 17
2021 18
2022 21
2023 26
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for port cv
Search for Porto CV instead (1 results)
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.
Swindells S, Ramchandani R, Gupta A, Benson CA, Leon-Cruz J, Mwelase N, Jean Juste MA, Lama JR, Valencia J, Omoz-Oarhe A, Supparatpinyo K, Masheto G, Mohapi L, da Silva Escada RO, Mawlana S, Banda P, Severe P, Hakim J, Kanyama C, Langat D, Moran L, Andersen J, Fletcher CV, Nuermberger E, Chaisson RE; BRIEF TB/A5279 Study Team. Swindells S, et al. N Engl J Med. 2019 Mar 14;380(11):1001-1011. doi: 10.1056/NEJMoa1806808. N Engl J Med. 2019. PMID: 30865794 Free PMC article. Clinical Trial.
Contrast examination of central venous access port implanted through internal jugular vein for evaluation of suspected complications.
Iguchi T, Hiraki T, Matsui Y, Tomita K, Uka M, Umakoshi N, Kajita S, Komaki T, Gobara H, Kanazawa S. Iguchi T, et al. Jpn J Radiol. 2021 Nov;39(11):1103-1110. doi: 10.1007/s11604-021-01142-4. Epub 2021 May 22. Jpn J Radiol. 2021. PMID: 34021855
Contrast examination was performed due to three suspicion catheter fractures or 54 CV-port dysfunctions (combinations of an absence of blood reflux on aspiration and 9 sufficient, 21 insufficient, or 24 impossible drip infusions). ...CONCLUSION: Contrast examination …
Contrast examination was performed due to three suspicion catheter fractures or 54 CV-port dysfunctions (combinations of an ab …
Central venous access port placement by translumbar approach using angio-CT unit in patients with superior vena cava syndrome.
Kariya S, Nakatani M, Maruyama T, Ono Y, Ueno Y, Komemushi A, Tanigawa N. Kariya S, et al. Jpn J Radiol. 2018 Jul;36(7):450-455. doi: 10.1007/s11604-018-0742-3. Epub 2018 May 9. Jpn J Radiol. 2018. PMID: 29744732
PURPOSE: To evaluate the clinical results of central venous access port (CV port) placement by translumbar inferior vena cava cannulation using angio-CT unit for cancer patients with superior vena cava syndrome. MATERIALS AND METHODS: A CV port …
PURPOSE: To evaluate the clinical results of central venous access port (CV port) placement by translumbar inferior ven …
Safety of Early Bevacizumab Administration after Central Venous Port Placement for Patients with Colorectal Cancer.
Shigyo H, Suzuki H, Tanaka T, Moriyama E, Shimotsuura Y, Nagasu S, Iwamoto H, Akagi Y, Murotani K, Kawaguchi T, Miwa K. Shigyo H, et al. Cancers (Basel). 2023 Apr 12;15(8):2264. doi: 10.3390/cancers15082264. Cancers (Basel). 2023. PMID: 37190192 Free PMC article.
However, the safety of BEV administration immediately after surgical placement of the central venous (CV) port, a minor surgery, is still unclear. This study aimed to investigate whether BEV is safe when administered early after CV port placement. ...I …
However, the safety of BEV administration immediately after surgical placement of the central venous (CV) port, a minor surger …
Risk factors for unsuccessful removal of central venous access ports implanted in the forearm of adult oncologic patients.
Kinoshita M, Takao S, Hiraoka J, Takechi K, Akagawa Y, Osaki K, Ohnishi N, Tani H. Kinoshita M, et al. Jpn J Radiol. 2022 Apr;40(4):412-418. doi: 10.1007/s11604-021-01214-5. Epub 2021 Nov 15. Jpn J Radiol. 2022. PMID: 34779983 Free PMC article.
PURPOSE: To evaluate the risk factors for unsuccessful removal of a central venous access port (CV port) implanted in the forearm of adult oncologic patients. ...CONCLUSION: The indwelling period is an independent risk factor for unsuccessful removal of a …
PURPOSE: To evaluate the risk factors for unsuccessful removal of a central venous access port (CV port) implanted in t …
Non-invasive imaging as the cornerstone of cardiovascular precision medicine.
Achenbach S, Fuchs F, Goncalves A, Kaiser-Albers C, Ali ZA, Bengel FM, Dimmeler S, Fayad ZA, Mebazaa A, Meder B, Narula J, Shah A, Sharma S, Voigt JU, Plein S. Achenbach S, et al. Eur Heart J Cardiovasc Imaging. 2022 Mar 22;23(4):465-475. doi: 10.1093/ehjci/jeab287. Eur Heart J Cardiovasc Imaging. 2022. PMID: 35048106 Review.
AIMS: To provide an overview of the role of cardiovascular (CV) imaging in facilitating and advancing the field of precision medicine in CV disease. METHODS AND RESULTS: Non-invasive CV imaging is essential to accurately and efficiently phenotype patients wit …
AIMS: To provide an overview of the role of cardiovascular (CV) imaging in facilitating and advancing the field of precision medicine …
Septic pulmonary embolism and subsequent bilateral pneumothorax in patients undergoing chemoradiotherapy for head angiosarcoma: An autopsy case report and literature review.
Ikejiri K, Goto H, Usui M, Nakayama Y, Sugioka K, Ito A, Suzuki K, Hirokawa Y, Yamanaka K, Imai H. Ikejiri K, et al. Medicine (Baltimore). 2022 Nov 11;101(45):e31755. doi: 10.1097/MD.0000000000031755. Medicine (Baltimore). 2022. PMID: 36397415 Free PMC article. Review.
We report a case of SPE and pneumothorax caused by central venous port (CV port) infection. PATIENT CONCERNS: A 73-year-old woman, who underwent chemoradiotherapy for a head angiosarcoma and a CV port placement, presented with general malaise an …
We report a case of SPE and pneumothorax caused by central venous port (CV port) infection. PATIENT CONCERNS: A 73-year …
Upper arm central venous port implantation: a 6-year single institutional retrospective analysis and pictorial essay of procedures for insertion.
Shiono M, Takahashi S, Kakudo Y, Takahashi M, Shimodaira H, Kato S, Ishioka C. Shiono M, et al. PLoS One. 2014 Mar 10;9(3):e91335. doi: 10.1371/journal.pone.0091335. eCollection 2014. PLoS One. 2014. PMID: 24614412 Free PMC article.
BACKGROUND: The requirement of central venous (CV) port implantation is increasing with the increase in the number of cancer patients and advancement in chemotherapy. ...RESULTS: Both groups had similar patient characteristics. Upper arm CV port and su …
BACKGROUND: The requirement of central venous (CV) port implantation is increasing with the increase in the number of cancer p …
What is the effect on cardiovascular events of reducing hyperuricemia with allopurinol? An evidence-based review.
Guedes M, Esperança A, Pereira AC, Rego C. Guedes M, et al. Rev Port Cardiol. 2014 Nov;33(11):727-32. doi: 10.1016/j.repc.2014.06.002. Epub 2014 Nov 20. Rev Port Cardiol. 2014. PMID: 25444231 Free article. Review. English, Portuguese.
INTRODUCTION: High levels of uric acid (UA) have been associated with cardiovascular (CV) disease, but its role as an independent risk factor is the subject of debate. Treating hyperuricemia may be useful in reducing CV risk. OBJECTIVE: To review the evidence on the …
INTRODUCTION: High levels of uric acid (UA) have been associated with cardiovascular (CV) disease, but its role as an independent ris …
Effect of empagliflozin beyond glycemic control: Cardiovascular benefit in patients with type 2 diabetes and established cardiovascular disease.
Monteiro P, Aguiar C, Matos P, Silva-Nunes J, Birne R, Branco P, Calado J, Melo M, Polónia J. Monteiro P, et al. Rev Port Cardiol (Engl Ed). 2019 Oct;38(10):721-735. doi: 10.1016/j.repc.2019.02.008. Epub 2019 Dec 28. Rev Port Cardiol (Engl Ed). 2019. PMID: 31892455 Free article. Review. English, Portuguese.
The prevalence of type 2 diabetes (T2D) continues to increase, and its association with cardiovascular (CV) disease has led to the inclusion of CV endpoints in clinical trials on the treatment of T2D. ...In this trial, empagliflozin, a sodium-glucose co-transporter …
The prevalence of type 2 diabetes (T2D) continues to increase, and its association with cardiovascular (CV) disease has led to the in …
238 results